Pfizer says its antiviral pill slashes risk of severe Covid-19 by 89%
The data has not yet been published or peer-reviewed, but Pfizer said in a news release that it would submit the data to regulators “as soon as possible
The data has not yet been published or peer-reviewed, but Pfizer said in a news release that it would submit the data to regulators “as soon as possible